enVVeno Medical (NVNO) Shares Outstanding (Weighted Average) (2017 - 2026)

enVVeno Medical has reported Shares Outstanding (Weighted Average) for 10 years, with the latest figure at $654000.0 in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 12.56% year-over-year to $654000.0; the trailing twelve-month figure through Mar 2026 stood at $654000.0 (up 12.56% YoY), and the FY2025 full-year result was $589000.0, up 20.2% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $654000.0, up from $589000.0 in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $20.4 million in Q2 2025, with the low at $490000.0 in Q4 2024.
• Average Shares Outstanding (Weighted Average) over 5 years is $10.7 million, with a median of $11.2 million recorded in 2023.
• Year-over-year, Shares Outstanding (Weighted Average) surged 156729.61% in 2022 and tumbled 96.38% in 2025.
• Tracing NVNO's Shares Outstanding (Weighted Average) over 5 years: stood at $11.2 million in 2022, then grew by 9.54% to $12.3 million in 2023, then sank by 96.02% to $490000.0 in 2024, then gained by 20.2% to $589000.0 in 2025, then advanced by 11.04% to $654000.0 in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $654000.0 (Q1 2026), $589000.0 (Q4 2025), and $20.2 million (Q3 2025), per Business Quant data.

Peer Comparison